Recombinant attenuated Toxoplasma gondii expressing the Plasmodium yoelii circumsporozoite protein provides highly effective priming for CD8+ T cell-dependent protective immunity against malaria

Journal of Immunology

Volumn 165, Issue 4, 2000, Pages 2084-2092

  Charest, H ^a   Sedegah, M ^a   Yap, G S ^a   Gazzinelli, R T ^a   Caspar, P ^a   Hoffman, S L ^a   Sher, A ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MALARIA VACCINE; PROTOZOAL PROTEIN; RECOMBINANT TS 4; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; DOSE RESPONSE; FEMALE; MALARIA; MOUSE; NONHUMAN; PARASITE IMMUNITY; PLASMODIUM YOELII; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRAIN DIFFERENCE; TOXOPLASMA GONDII;

EID: 0034663924     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.4.2084     Document Type: Article

References (52)

1. Recombinant vaccine delivery systems and encoded vaccines
2. Resistance to murine tumors conferred by chronic infection with intracellular protozoa, Toxoplasma gondii and Besnoitia jellisoni
3. Acquired resistance to infection with Schistosoma mansoni induced by Toxoplasma gondii
4. Specific and nonspecific mediation of protective immunity to Toxoplasma gondii
5. Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection
6. Gene replacement in Toxoplasma gondii with chloramphenicol acetyltransferase as selectable marker
7. Transient transfection and expression in the obligate intracellular parasite Toxoplasma gondii
8. Stable DNA transformation in the obligate intracellular parasite Toxoplasma gondii by complementation of tryptophan auxotrophy
9. Homologous recombination and gene replacement at the dihydrofolate reductase-thymidylate synthase locus in Toxoplasma gondii
10. Insertional tagging, cloning, and expression of the Toxoplasma gondii hypoxanthine-xanthineguanine phosphoribosyltransferase gene: Use as a selectable marker for stable transformation
11. Virulence of different strains of Toxoplasma gondii and host response in mice
12. Virulent strains of Toxoplasma gondii comprise a single clonal lineage
13. Temperature-sensitive mutants of Toxoplasma gondii: Pathogenicity and persistence in mice
14. Toxoplasma gondii: Isolation and preliminary characterization of temperature-sensitive mutants
15. + T cells in mice
16. + T lymphocytes in IFN-γ production and protective immunity induced by an attenuated Toxoplasma gondii vaccine
17. T cell responses to pre-erythrocytic stages of malaria: Role in protection and vaccine development against pre-erythrocytic stages
18. + cell-, interferon γ-, and nitric oxide- dependent immunity
19. Immune effector mechanisms in malaria
20. + T cells in the Plasmodium yoelii model
21. Recombinant pseudorabies virus carrying a Plasmodium gene: Herpesvirus as a new live viral vector for inducing T- and E-cell immunity
22. + T-cell-mediated protective immunity against malaria
23. + T and B cell epitopes: Comparison of their immunogenicity and capacity to induce protective immunity
24. Partial protection against malaria by immunization with Leishmania enriettii expressing the Plasmodium yoelii circumsporozoite protein
25. + T cell-mediated protective immunity against malaria
26. Protection from Plasmodium berghei infection by priming and boosting T cells to a single class I-restricted epitope with recombinant carriers suitable for human use
27. The protozoan parasite Toxoplasma gondii targets proteins to dense granules and the vacuolar space using both conserved and unusual mechanisms
28. Structure of the gene encoding the circumsporozoite protein of Plasmodium yoelii: A rodent model for examining antimalarial sporozoite vaccines
29. Characterization of Plasmodium yoelii monoclonal antibodies directed against stage-specific sporozoite antigens
30. Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine
31. IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block T cell-mediated cytolysis in the absence of complement
32. Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: Similarity of L3T4 to the human Leu-3/T4 molecule
33. + T lymphocytes in early IFN-γ-dependent resistance to Toxoplasma gondii
34. Biochemical characterization and protein kinase C dependency of monokine-inducing activities of Toxoplasma gondii
35. Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein
36. In the absence of endogenous IFN-γ, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection
37. + T cells against a previously unrecognized cryptic epitope of the circumsporozoite protein
38. Monoclonal, but not polyclonal, antibodies protect against Plasmodium yoelii sporozoites
39. Interleukin 12 induction of interferon γ-dependent protection against malaria
40. Sterile protection of monkeys against malaria after administration of interleukin-12
41. Transformed Toxoplasma gondii tachyzoites expressing the circumsporozoite protein of Plasmodium knowlesi elicit a specific immune response in rhesus monkeys
42. Partially protective vaccination permits the development of latency in a normally virulent strain of Toxoplasma gondii
43. Interferon-γ: The major mediator of resistance against Toxoplasma gondii
44. + T cells from mice vaccinated against Toxoplasma gondii are cytotoxic for parasite-infected or antigen-pulsed host cells
45. Perforin-mediated cytolysis plays a limited role in host resistance to Toxoplasma gondii
46. Comparison of circumsporozoite proteins from avian and mammalian malarias: Biological and phylogenetic implications
47. Protection against malaria by vaccination with sporozoite surface protein 2 plus CS protein
48. Intact immune defenses are required for mice to resist the ts-4 vaccine strain of Toxoplasma gondii
49. + T cell response by IFN-γ in IL-12-deficient mice during Toxoplasma a gondii infection
50. Immunization with heat-killed Toxoplasma gondii stimulates an early IFN-γ response and induces protection against virulent murine malaria
51. + T cell immunogenicity and protective efficacy in the influenza and malaria models
52. Strategies to reduce transmission of Toxoplasma gondii to animals and humans